These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contraindicated antiretroviral drug combinations. Macher A; Thomas D; Paul SM N J Med; 2003 Sep; 100(9 Suppl):41-3; quiz 73-4. PubMed ID: 14556602 [TBL] [Abstract][Full Text] [Related]
3. Adverse interactions with antiretroviral agents: focus on recreational and addiction drugs. Vassilev ZP; Marcus SM AIDS Read; 2004 Feb; 14(2):96. PubMed ID: 15083804 [No Abstract] [Full Text] [Related]
5. Anti-HIV drugs. De Clercq E Verh K Acad Geneeskd Belg; 2007; 69(2):81-104. PubMed ID: 17550060 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients. Marfo K; Greenstein S Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390 [TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience. Joly V; Yeni P Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761 [TBL] [Abstract][Full Text] [Related]
10. Update on HAART in HIV. Yeni P J Hepatol; 2006; 44(1 Suppl):S100-3. PubMed ID: 16359748 [TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists. Berns JS; Kasbekar N Clin J Am Soc Nephrol; 2006 Jan; 1(1):117-29. PubMed ID: 17699198 [TBL] [Abstract][Full Text] [Related]
12. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Neuman MG; Monteiro M; Rehm J Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection? Kourtis AP J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653 [No Abstract] [Full Text] [Related]
18. Treatment interruption in HIV therapy: a SMART strategy? Jülg B; Goebel FD Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667 [TBL] [Abstract][Full Text] [Related]
19. [Antiretroviral treatment for HIV infection. Where we are and where we are going?]. Sierra-Madero JG; Franco-San-Sebastián D Rev Invest Clin; 2004; 56(2):222-31. PubMed ID: 15377075 [TBL] [Abstract][Full Text] [Related]
20. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]